Reported Q: Q3 2024 Rev YoY: N/A EPS YoY: +22.7% Move: +2.16%
New Horizon Aircraft Ltd
HOVR
$1.890 2.16%
Exchange NASDAQ Sector Industrials Industry Aerospace Defense
Q3 2024
Published: Apr 14, 2025

Company Status Snapshot

Fast view of the latest quarter outcome for HOVR

Reported

Report Date

Apr 14, 2025

Quarter Q3 2024

Revenue

N/A

YoY: N/A

EPS

-0.17

YoY: +22.7%

Market Move

+2.16%

Previous quarter: Q2 2024

Follow this company to get upcoming quarter alerts automatically.

Earnings Highlights

  • EPS of $-0.17 increased by 22.7% from previous year
  • Net income of -4.94M
  • "N/A" - N/A
HOVR
Company HOVR

Executive Summary

New Horizon Aircraft Ltd (HOVR) reported QQ3 2024 results with no revenue disclosed and a negative operating income of $3.554 million, producing a net loss of $4.943 million and an EPS of -$0.17. The quarter followed a markedly different QQ2 2024, which featured a substantial one-time gain from total other income/expenses of $22.94 million, resulting in a net income of $19.66 million for that earlier quarter. The QQ3 results highlight the companyโ€™s ongoing pre-revenue status as it advances its hybrid-electric eVTOL program, with operating losses driven by development and G&A spending rather than commercial sales. Despite the profitability swing QoQ, the company maintains strong liquidity, underscored by a cash balance of $9.20 million and a net cash position (net debt of โˆ’$9.16 million) driven by financing activity and equity issuance.

From a cash-flow perspective, QQ3 2024 cash from operations was negative at $2.62 million, reflecting working capital dynamics and ongoing operating expenditures, while investing cash outflows were modest at $0.09 million. Financing activity contributed $11.02 million, including stock-issuance proceeds of $2.09 million and other financing activities totaling $8.94 million, driving a net increase in cash of $8.31 million for the period. The balance sheet shows total assets of $10.33 million with negligible debt ($0.035 million total debt) and total stockholdersโ€™ equity of about $6.997 million, reinforcing a favorable liquidity position for continuing R&D and prototype development.

Looking ahead, the near-term trajectory remains closely tied to development milestones for the Cavorite X7 program and potential strategic partnerships or government/defense opportunities. The QQ3 2024 results suggest that profitability hinges on transitioning from development-phase expenditures to productization and demonstration milestones, followed by revenue generation. Investors should monitor product milestones, external funding needs, and any qualitative guidance on timelines to revenue realization as management communicates progress with customers, regulators, and potential partners.

Key Performance Indicators

Operating Income
Decreasing
-3.55M
QoQ: -8.55% | YoY: -182.29%
Net Income
Decreasing
-4.94M
QoQ: -125.14% | YoY: -25.28%
EPS
Increasing
-0.17
QoQ: -120.48% | YoY: 22.73%

Revenue Trend

Margin Analysis

Historical Earnings Comparison

PeriodRevenue ($M)EPS ($)YoY GrowthReport
Q2 2026 0.00 -0.21 +0.0% View
Q1 2026 0.00 -0.29 +0.0% View
Q3 2024 0.00 -0.17 +0.0% View
Q2 2024 0.00 0.80 +0.0% View
Q1 2024 0.00 -0.15 +0.0% View